Steward Health Care Sells Hospitals Amid Challenges
Steward Health Care has recently faced significant challenges but has managed to secure court approval for the sale of six of its hospitals during a contentious hearing. These transactions brought in a total of $243 million, which will help the health care system exit operations in the state and address its financial difficulties.
The health system will transfer St. Anne’s Hospital and Morton Hospital to Rhode Island's Lifespan Health System for $175 million. Additionally, St. Elizabeth’s Medical Center and Good Samaritan Medical Center will be sold to Boston Medical Center for $140 million, while Lawrence General Hospital will acquire both Holy Family Hospital campuses for $28 million. These strategic sales are intended to provide critical support as Steward navigates ongoing financial challenges.
Financial Impact of Hospital Sales
While the sales may seem like a positive development, they cast a shadow over Steward Health Care's future. Candace Arthur, a partner at Weil, Gotshal & Manges, notes that after accounting for purchase price adjustments and closing costs, Steward could find itself about $17 million deeper in financial trouble.
Apollo Global Management, a prominent private equity and asset management firm, plays a key role in these transactions, expected to gain around $225 million. The firm now holds the mortgages associated with these hospitals, which are owned by Medical Properties Trust and Macquarie Infrastructure Partners. The intricate negotiations surrounding these deals highlight the significant financial strains faced by Steward, especially in terms of how to allocate the proceeds from the sales among various operational and real estate obligations.
Legal and Operational Challenges
Steward Health Care is under scrutiny from its lenders. The organization’s FILO lenders, including WhiteHawk Finance and Brigade Capital, have expressed concerns about the sale, arguing that selling the hospitals at a loss jeopardizes their security interests. Throughout the restructuring process, these lenders have provided approximately $575 million in operational funding, underscoring Steward's reliance on these financial supporters.
During court proceedings, the lenders’ attorney, Michael Price, voiced concerns regarding the collateral agreements that link hospital assets to their financing. He pointed out that the proposed sales do not sufficiently compensate secured lenders for their interests, raising questions about the actual value being returned to the estate.
Looking Ahead in the Healthcare Landscape
U.S. Bankruptcy Judge Christopher Lopez approved the hospital sales, deeming them the best available option given the circumstances. However, he has withheld about $17 million from the deal until a further assessment of how to allocate these proceeds is completed.
Steward is required to finalize these transactions by the end of September, and the entire process will continue to undergo state and regulatory reviews. Although the timeline is tight, the potential benefits of these sales extend beyond financial recovery; they are vital for preserving jobs and ensuring operational stability in local healthcare.
CEO's Noncompliance with Subpoena
In the midst of these developments, Steward’s CEO, Ralph de la Torre, has attracted attention for his refusal to testify before a Senate committee regarding his involvement in the organization’s financial matters. This decision has drawn significant criticism, particularly from committee chair Sen. Bernie Sanders, who has stressed the importance of accountability.
Steward Health Care has opted not to comment on this situation, but the ramifications of such choices could affect the organization’s reputation and complicate its restructuring efforts further. Senators have labeled the executive’s absence from the hearing as unacceptable, threatening to hold him in contempt if he continues to avoid testifying.
Future Sales and Restructuring Plans
Looking ahead, Steward plans to hold a sale hearing for its hospitals in Florida, with hopes that this new transaction will significantly improve its financial standing. Unlike the Massachusetts deal, this upcoming agreement with Orlando Health is designed to preserve value that the health system can utilize to pay back lenders and creditors.
As the restructuring process continues, additional developments regarding future sales in Ohio and other regions suggest that the health system is still navigating a complex negotiation phase, highlighting the ongoing challenges it faces.
Frequently Asked Questions
What did Steward Health Care recently achieve?
Steward Health Care received court approval to sell six hospitals for $243 million, marking a significant step in their financial restructuring.
Why does the sale leave Steward in a deficit?
After adjusting for purchase price changes and closing costs, the hospital sales could leave Steward approximately $17 million further in the hole.
What role does Apollo Global Management play in these transactions?
Apollo Global Management is set to net around $225 million from the hospital sales, handling mortgages tied to Steward's Massachusetts facilities.
How are lenders reacting to the sale?
FILO lenders are objecting to the sale of the hospitals at a loss, arguing it jeopardizes their security interests in the company.
What are the next steps for Steward Health Care?
Steward must finalize its hospital sales by the end of September, while also preparing for additional hearings regarding other facilities in Florida and Ohio.
